Two Sigma Securities’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Two Sigma Securities’s Portfolio SYRS Stock Details SYRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-107,742	Closed	-$24.8K	–	2373
2024 Q4	$24.8K	Buy	+107,742	New	+$129K	﹤0.01%	1283

Other funds holding SYRS

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

1CM

1492 Capital Management Milwaukee, Wisconsin $263M AUM 61.9% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Two Sigma Securities's SYRS Position: Q1 2025 in Review

Two Sigma Securities sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q1 2025, closing a stake of 107,742 shares — an estimated $24.8K sold.

Two Sigma Securities first reported a position in SYRS in Q4 2024 and held it in 1 quarter. The position peaked at $24.8K in Q4 2024. 7 funds tracked by Wall St. Rank hold SYRS as of Q1 2025.

Two Sigma Securities reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Two Sigma Securities sold 107,742 Syros Pharmaceuticals, Inc. Common Stock shares in Q1 2025, an estimated $24.8K.
Two Sigma Securities first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
Two Sigma Securities's Syros Pharmaceuticals, Inc. Common Stock position peaked at $24.8K in Q4 2024.
7 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q1 2025.

Based on Two Sigma Securities's 13F filing for Q1 2025, filed 15 May 2025.